AZNAstraZenecaRunning, no new patients
Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
Ovarian Cancer · Breast Cancer
0Calmworry score, out of 100
No strong warning signs right now. The score counts warning signs; it is not a prediction.
Why this score
No warning signs right now. That's why the score is 0.
Score over time
- Stage
- Phase 3
- Patients
- 185 (final count)
- Started
- Aug 4, 2020
- Main results expected
- Apr 6, 2027
- Fully finished
- Apr 6, 2027
- Results posted
- not yet
What counts as success
The trial's main goal(s), called the “primary outcome.”
Safety follow up
Measured over: Baseline up to approximately 10 years
Changes Tremor has spotted
No changes since Tremor started watching this trial.
Show details (technical version)
Score inputs
- none
Raw record changes
- none yet
Trial ID NCT04421963 · record last updated 2026-06-12 · checked 2026-11-09 15:47 UTC